The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3,4-dichlorophenyl)-6-(methyloxy)-7-[({5-[4-(methyloxy)phenyl]-1,2,4-oxadiazol-3-yl}methyl)oxy]quinazolin-4-amine ID: ALA3985840
PubChem CID: 57802896
Max Phase: Preclinical
Molecular Formula: C25H19Cl2N5O4
Molecular Weight: 524.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)cc1
Standard InChI: InChI=1S/C25H19Cl2N5O4/c1-33-16-6-3-14(4-7-16)25-31-23(32-36-25)12-35-22-11-20-17(10-21(22)34-2)24(29-13-28-20)30-15-5-8-18(26)19(27)9-15/h3-11,13H,12H2,1-2H3,(H,28,29,30)
Standard InChI Key: VKCKBMWVXBACHI-UHFFFAOYSA-N
Molfile:
RDKit 2D
36 40 0 0 0 0 0 0 0 0999 V2000
23.3433 -13.5111 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0530 -13.1017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0502 -12.2790 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.3415 -11.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6353 -13.1021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.6376 -12.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9316 -11.8753 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2229 -12.2829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.2246 -13.1038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.9311 -13.5091 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5152 -11.8744 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.5150 -11.0572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.5179 -13.5140 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.3380 -11.0565 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.0440 -10.6449 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7529 -11.0519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4584 -10.6410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.4553 -9.8229 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.7409 -9.4176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.0384 -9.8308 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.1607 -9.4104 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.1676 -11.0469 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
19.8092 -13.1071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1025 -13.5174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3565 -13.1882 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.8112 -13.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2215 -14.5036 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.0203 -14.3317 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0028 -13.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6694 -12.9670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8573 -12.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3776 -13.5459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7159 -14.2945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5270 -14.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5646 -13.4635 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2295 -12.7182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 2 0
8 11 1 0
11 12 1 0
9 13 1 0
4 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
17 22 1 0
13 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 1 0
28 24 2 0
29 30 2 0
30 31 1 0
31 32 2 0
32 33 1 0
33 34 2 0
34 29 1 0
26 29 1 0
32 35 1 0
35 36 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 524.36Molecular Weight (Monoisotopic): 523.0814AlogP: 6.33#Rotatable Bonds: 8Polar Surface Area: 104.42Molecular Species: NEUTRALHBA: 9HBD: 1#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: ┄CX Basic pKa: 4.93CX LogP: 5.88CX LogD: 5.88Aromatic Rings: 5Heavy Atoms: 36QED Weighted: 0.25Np Likeness Score: -1.49
References 1. (2009) Receptor-type kinase modulators and methods of use,